Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Substance Tapentadol, Atc N02ax06 For The Period 01.11.2022 - 31.10.2024

DAK-GESUNDHEIT Germany has Released a tender for Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Substance Tapentadol, Atc N02ax06 For The Period 01.11.2022 - 31.10.2024 in Pharmaceuticals. The tender was released on Sep 22, 2022.

Country - Germany

Summary - Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Substance Tapentadol, Atc N02ax06 For The Period 01.11.2022 - 31.10.2024

Deadline - login to view

MT reference number - 10271762

Product classification - Injectable solutions

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10271762

  Document Type - Tender Notices

Notice Details and Documents:

Description - Contract notice: Conclusion of a non-exclusive discount agreement according to § 130a para. 8 sgb v on the active substance tapentadol, atc n02ax06 for the period 01.11.2022 - 31.10.2024§ 130a paragraph 8 sgb v enables the health insurance companie s and pharmaceutical companies to conclude framework discount agreements for the drugs to be dispensed at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures takes place according to the regulations of the 4th part of the GWB by the dak health. for medicinal products to be specified by the bi

Mt Ref Id - 10271762

Deadline - Sep 05, 2024

Share

Similar Tenders :